Related Experiment Videos
Prenatal diagnosis and control strategies for beta-thalassaemia on the Indian subcontinent
1Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Insights
Prenatal diagnosis for beta-thalassaemia is crucial in India due to resource limitations. Identifying common mutations is key for effective prenatal diagnosis programs and community-based control.
Area of Science:
- Genetics
- Molecular Biology
- Public Health
Background:
- Beta-thalassaemia is a prevalent genetic disorder in India, posing a significant public health challenge.
- Limited resources for treating affected children necessitate effective control strategies like prenatal diagnosis.
- DNA analysis of chorionic villus samples is the current standard for prenatal diagnosis.
Purpose of the Study:
- To characterize the spectrum of beta-thalassaemia mutations in the Indian population.
- To establish a foundation for implementing a robust prenatal diagnosis program.
- To inform the development of community-based beta-thalassaemia control initiatives.
Main Methods:
- Analysis of beta-thalassaemia mutations in 708 unrelated carriers from seven distinct regions.
- Utilized allele-specific polymerase chain reaction and DNA sequencing for mutation characterization.
Main Results:
- Identified sixteen distinct beta-thalassaemia mutations.
- Five common mutations accounted for 93% of all identified alleles.
- Observed significant regional variations in mutation frequency and distribution across India.
Conclusions:
- The characterized mutation spectrum provides essential data for India's beta-thalassaemia prenatal diagnosis program.
- A practical strategy for mutation detection has been successfully outlined.
- Recommendations are proposed for a community-based thalassaemia control program, leveraging simplified prenatal diagnosis.
Background:
The control of beta-thalassaemia by prenatal diagnosis is an important option in India. The disease is common and resources are scarce for the treatment of affected children. Presently the most suitable approach for prenatal diagnosis is DNA analysis of a chorion villus sample by direct mutation detection. For the implementation of such a prenatal diagnosis programme it is essential to know the spectrum of beta-thalassaemia mutations in the population.
Method:
The beta-thalassaemia mutations of 708 unrelated carriers from seven different regions of the Indian subcontinent were characterized by the allele-specific polymerase chain reaction and DNA sequencing.
Results:
Sixteen different beta-thalassaemia mutations were identified which could be divided into three groups according to their frequencies. Five common mutations accounted for 93% of alleles. Significant regional differences in the frequency and distribution of mutations were observed.
Conclusions:
The spectrum of mutations defined forms the basis for a beta-thalassaemia prenatal diagnosis programme in India. A strategy has been outlined for mutation detection which could be successfully applied. Since prenatal diagnosis has become comparatively simple, recommendations are made for a community-based thalassaemia control programme.